PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2019 | 9 | 2 | 51-54
Article title

The young breast cancer patient therapy – new opportunities, new challenges

Content
Title variants
Languages of publication
EN
Abstracts
EN
The paper describes the case of a 31-year-old female patient with breast cancer with the abdominal metastases. This disease in young people usually has a more aggressive biological subtype, which significantly worsens the prognosis. In this patient aggressive treatment was used. It was effective and did not cause severe or long-term complications.
Discipline
Publisher

Journal
Year
Volume
9
Issue
2
Pages
51-54
Physical description
Contributors
  • Department of Electroradiology, Poznan University of Medical Sciences
References
  • 1. Batist G, Remakrishnan G, Rao CS et al. Reduced cardiotoxity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin with cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. J Clin Oncol 2001; 19: 1444-54.
  • 2. Batist G, Harris L, Azarina N et al. Improved anti-tumor response rate with decreased cardiotoxity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who haved received prior adjuvant doxorubicin: results of a retrospective analysys. Anticancer Drugs 2006; 17: 587-95.
  • 3. Meiyuan X, Feifei Y, Sufen Y, Peng S. Efficacy and cardiotoxicity of liposomal doxorubicin-based chemotherapy in advanced breast cancer: a meta-analysis of ten randomized trials. PloS One 2015; 10(7): e0133569
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-a1b26eb5-292e-493f-b392-c48e225aba16
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.